Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End-use (Academic & Research Institutes), By Region, And Segment Forecasts, 2024 - 2030
Human Liver Model Market Size & Trends
The global human liver model market size was estimated at USD 1.19 billion in 2023 and is projected to grow at a CAGR of 13.8% from 2024 to 2030. The market is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected to propel its growth.
According to the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set to transform healthcare by addressing organ shortages and improving patient care globally.
The prevalence of liver diseases is on the rise globally, leading to a growing demand for advanced research tools include Human Liver Model. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due to factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient Human Liver Model to support research and drug development efforts.
Organ 3D printing technologies have advanced significantly recently, particularly in developing Human Liver Model. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Diego made significant progress in addressing challenging issues in bio printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution.
Global Human Liver Model Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global human liver model market report based on product, application, end-use, and region:
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- 2D Models
- Cell lines
- Primary Cells
- 3D Models
- Liver on Chip
- Organoids
- Spheroids
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- ADME Studies
- Toxicology Testing
- Disease Modelling
- Others
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Human Liver Model Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of liver diseases
- 3.2.1.2. Advancements in organ printing technologies
- 3.2.1.3. Increased demand for therapeutic drugs for liver cancer
- 3.2.2. Market restraint analysis
- 3.2.2.1. High costs and complexity associated with maintaining Human Liver Model
- 3.3. Human Liver Model Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
- Chapter 4. Human Liver Model Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Human Liver Model Market Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. 2D Models
- 4.4.1. 2D models market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Cell Lines
- 4.4.2.1. Cell Lines market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Primary Cells
- 4.4.3.1. Primary Cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. 3D Models
- 4.5.1. 3D models market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Liver on Chip
- 4.5.2.1. Liver on Chip market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Organoids
- 4.5.3.1. Organoids market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.4. Spheroids
- 4.5.4.1. Spheroids market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.5. Others
- 4.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 5. Human Liver Model Market: Application Estimates & Trend Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global Human Liver Model Market Application Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. ADME Studies
- 5.4.1. ADME Studies market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Toxicology Testing
- 5.5.1. Toxicology Testing market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Disease Modelling
- 5.6.1. Disease Modelling market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 6. Human Liver Model Market: End Use Estimates & Trend Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global Human Liver Model Market End Use Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Global Human Liver Model Market Size and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Academic & Research Institutes
- 6.4.1. Academic & Research Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Pharmaceutical & Bioproduct Companies
- 6.5.1. Pharmaceutical & Bioproduct Companies market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Contract Research Organizations
- 6.6.1. Contract Research Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 7. Human Liver Model Market: Regional Estimates & Trend Analysis
- 7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Share Analysis, 2023 & 2030
- 7.4. North America
- 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.7. Denmark
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Competitive scenario
- 7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Competitive scenario
- 7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.9. Norway
- 7.5.9.1. Key country dynamics
- 7.5.9.2. Competitive scenario
- 7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive scenario
- 7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive scenario
- 7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive scenario
- 7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Company Profiles
- 8.4.1. ATCC
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Merck KGaA
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. AcceGen
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. ZenBio, Inc.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Organovo Holdings Inc.
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. BioIVT
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. InSphero
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Emulate, Inc.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Mimetas
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. CN Bio Innovations Ltd
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook